Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-10

Clinical Trial Update: Intranasal Insulin for Weight Management During Smoking Cessation [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intranasal insulin for weight management during tobacco abstinence; completed with posted results in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intranasal insulin (insulin)

Snippet

Sponsor: Ajna Hamidovic | Conditions: Tobacco Abstinence Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-12-10